Patient Group Direction: Ciprofloxacin under 12 (Anthrax)

Document first published:
Page updated:
Topic:
,
Publication type:

Patient Group Direction (PGD) for the initial supply of ciprofloxacin tablets or suspension to children aged under 12 years of age with known or suspected exposure to anthrax.

Document

Patient Group Direction: Ciprofloxacin under 12 (Anthrax)

Patient Group Direction: Ciprofloxacin under 12 (Anthrax)

  • Microsoft Word
  • 157 KB
  • 13 pages